Login
← Go Back
Gufic Biosciences
GUFICBIO · Pharma > Pharmaceuticals & Drugs · Chairman: Jayesh P Choksi · MD: Jayesh P Choksi · Listing date: Oct. 20, 2004 · Employees: 1247 · Mumbai · http://gufic.com
Stock Price vs Company Growth
1d
0.5%
1w
1.3%
1m
3.9%
3m
6.7%
6m
2.4%
1y
27.3%
5y
22.8%
10y
19.8%
all
19.9%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 338 0.5%
312
375
Company Overview
Sales
874 Cr
Growth: 6.2%
Profit after Tax
56.9 Cr
Growth: -8.0%
Small Cap
3,391 Cr
P/E: 59.5x
Industry P/E: 33.1x
Fundamentals
Sales (Cr) ₹ 874
Growth 6.2%
EBITDA 15.0%
P/S 3.9x
Dividend 0.0%
P/E 59.5x
Book Value ₹ 1
PEG Ratio 9.7x
ROE 567.6%
P/B N/A
Shareholding Pattern
Institutions
Sbi Healthcare Opportunities Fund
2.61 %
Promoters
Mr. Jayesh P. Choksi
25.95 %
Zircon Teconica Private Limited (Formely Known As Zircon Finance & Leasing Private Limited)
21.17 %
Gufic Private Limited
10.51 %
Mr. Pranav J. Choksi
7.5 %
Others
Vipula Jayesh Choksi
10.35 %
Jagdish N Master
1.65 %
Iepf
0.21 %
Increase    Decrease    No change
Company Profile Detailed
The company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.Products of the companyPharmaceuticalHerbalAPI / Bulk DrugsPersonal careInternationalHistory and milestonePast InitiativesFirst Indian to produce Doxycycline Inj.First Indian company to make Liquid Oxytetracycline Inj.
Belongs to (8 Indices) view more
Investors (45)
icici.pr...
sbi.acti...
abhay4
Followers (8)
indrajee...
nihal
mrinmoy4